Iradimed Corp. (IRMD) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
IRADIMED CORPORATION Announces First Quarter 2015 Financial Results
April 30, 2015 7:01 AM EDTReports first quarter 2015 non-GAAP diluted EPS of $0.14 Revenue grows 96.5% compared to the same quarter last year Increases full year 2015 revenue and non-GAAP earnings guidance Announces second quarter financial guidance
WINTER SPRINGS, Fla., April 30, 2015 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (Nasdaq: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended March 31, 2015.
For the first quarter ended March 31, 2015, the Company reported revenue of $7.0... More
